teaser
Tina Hawkins
Rheumatology Pharmacist, Leeds Teaching Hospital NHS Trust
Professor Paul Emery
↓Article continues below this sponsored advert↓
↑Advertisement↑
President of European League Against Rheumatism, Arthritis UK Professor of Rhematology, University of Leeds, UK
Rheumatoid arthritis (RA) is a long-term, chronic,
autoimmune condition characterised by inflammation of the synovial joints combined with a number of systemic features resulting from abnormal immune response and secondary inflammation. Uncontrolled disease may result in significant morbidity and mortality.1 Early intervention with disease modifying anti-rheumatic drugs (DMARDs) is essential to prevent long term joint damage, reduce morbidity and improve the patient
